Rafael Castillo Selected Research

Rafael Castillo Research Topics

6	Neoplasms (Cancer) 11/2023 - 01/2018
6	Parasitic Diseases (Parasitic Disease) 07/2023 - 05/2012
4	Infections 09/2013 - 05/2007
3	Type 2 Diabetes Mellitus (MODY) 07/2022 - 12/2017
2	Leishmaniasis 01/2024 - 01/2018
2	Triple Negative Breast Neoplasms 02/2022 - 01/2021
2	Giardiasis 01/2020 - 04/2016
2	Neurocysticercosis 10/2019 - 04/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 06/2004
2	Cysts 09/2013 - 04/2009
1	Obesity 07/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Pathologic Complete Response 01/2021
1	Acute Coronary Syndrome 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Visceral Leishmaniasis (Kala Azar) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Carcinogenesis 01/2018
1	Insulin Resistance 12/2017
1	Cysticercosis 12/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Scimitar Syndrome 03/2014
1	Pathologic Constriction (Stenosis) 07/2013
1	Hypertrophy 07/2013
1	Trichinellosis 05/2013
1	Nematode Infections 04/2013
1	Mediastinitis 03/2013
1	Diabetes Mellitus 06/2012
1	Metabolic Diseases (Metabolic Disease) 06/2012
1	Atrial Heart Septal Defects (Atrial Septal Defect) 03/2011
1	Latent Tuberculosis 05/2007
1	Hyperlipidemias (Hyperlipidemia) 06/2004
1	Parotitis (Parotiditis) 06/2003
1	Tuberculosis (Tuberculoses) 06/2003

7	Albendazole (Albenza)FDA Link 07/2023 - 10/2007
5	benzimidazoleIBA 10/2019 - 10/2007
3	AnthelminticsIBA 07/2023 - 10/2007
3	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 07/2022 - 12/2017
2	Antiparasitic Agents (Antiparasitics)IBA 11/2023 - 09/2013
2	TubulinIBA 11/2023 - 01/2017
2	EnzymesIBA 07/2022 - 01/2018
2	Insulin (Novolin)FDA Link 10/2021 - 12/2017
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	nitazoxanide (NTZ)FDA Link 01/2020 - 04/2016
2	Protein Isoforms (Isoforms)IBA 10/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 12/2017 - 09/2013
2	Mebendazole (Anti-Worm)FDA Link 05/2013 - 10/2007
2	Tuberculin (PPD)IBA 05/2007 - 06/2003
1	Antineoplastic Agents (Antineoplastics)IBA 11/2023
1	carbendazimIBA 11/2023
1	HalogensIBA 02/2022
1	Estrogen ReceptorsIBA 01/2021
1	Cytoskeletal ProteinsIBA 01/2020
1	TroponinIBA 01/2019
1	Troponin IIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2018
1	miltefosine (Impavido)IBA 01/2018
1	Antimitotic AgentsIBA 01/2018
1	ArginaseIBA 01/2018
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2018
1	SolutionsIBA 03/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2012
1	Cysteine Proteases (Cysteine Protease)IBA 05/2012
1	TriclabendazoleIBA 01/2010
1	albendazole sulfoxideIBA 04/2009
1	Oleic Acid (Oleate)IBA 06/2004
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 06/2004
1	VitaminsIBA 06/2004
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2004
1	Folic Acid (Vitamin M)FDA LinkGeneric 06/2004
1	AntigensIBA 06/2003

4	Therapeutics 01/2021 - 06/2003
3	Drug Therapy (Chemotherapy) 01/2024 - 05/2013
2	Chemoprevention 05/2007 - 06/2003
1	Neoadjuvant Therapy 01/2021
1	Thoracotomy 03/2014
1	Fontan Procedure (Fontan Operation) 07/2013
1	Palliative Care (Palliative Therapy) 07/2013
1	Extracorporeal Circulation 03/2011